Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
126.05
-0.29 (-0.23%)
Jul 1, 2026, 3:50 PM EDT - Market open
Gilead Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 9,216 | 8,510 | 480 | 5,613 | 4,566 | 6,201 |
Depreciation & Amortization | 2,753 | 2,760 | 2,767 | 2,693 | 2,103 | 2,050 |
Stock-Based Compensation | 903 | 894 | 835 | 766 | 637 | 635 |
Other Adjustments | 969 | 1,803 | 7,626 | 1,236 | 3,529 | 2,009 |
Change in Receivables | -312 | -367 | 139 | 157 | -406 | 313 |
Changes in Inventories | -865 | -1,036 | -426 | -842 | -310 | 11 |
Changes in Accounts Payable | -94 | -132 | 290 | -347 | 226 | -118 |
Changes in Accrued Expenses | -452 | 6 | 108 | 458 | -775 | 689 |
Changes in Income Taxes Payable | -1,585 | -2,108 | -732 | -1,768 | -364 | -361 |
Changes in Other Operating Activities | -318 | -311 | -259 | 39 | -134 | -45 |
Operating Cash Flow | 10,215 | 10,019 | 10,828 | 8,006 | 9,072 | 11,384 |
Operating Cash Flow Growth | 18.55% | -7.47% | 35.25% | -11.75% | -20.31% | 36.40% |
Capital Expenditures | -576 | -563 | -523 | -585 | -728 | -579 |
Purchases of Investments | -4,600 | -4,072 | -736 | -2,372 | -1,942 | -3,897 |
Proceeds from Sale of Investments | 3,465 | 909 | 2,592 | 1,844 | 2,002 | 2,910 |
Payments for Business Acquisitions | -906 | -1,070 | -4,840 | -1,152 | -1,797 | -1,584 |
Other Investing Activities | 8 | 2 | 58 | -1 | -1 | 19 |
Investing Cash Flow | -2,608 | -4,793 | -3,449 | -2,265 | -2,466 | -3,131 |
Long-Term Debt Issued | - | - | 3,464 | 1,980 | - | - |
Long-Term Debt Repaid | -2,792 | -1,788 | -1,970 | -2,250 | -1,500 | -4,750 |
Net Long-Term Debt Issued (Repaid) | -2,792 | -1,788 | 1,494 | -270 | -1,500 | -4,750 |
Issuance of Common Stock | 322 | 408 | 422 | 232 | 309 | 169 |
Repurchase of Common Stock | -1,611 | -1,922 | -1,150 | -1,000 | -1,396 | -546 |
Net Common Stock Issued (Repurchased) | -1,289 | -1,514 | -728 | -768 | -1,087 | -377 |
Common Dividends Paid | -4,033 | -4,003 | -3,918 | -3,809 | -3,709 | -3,605 |
Other Financing Activities | -443 | -440 | -281 | -279 | -173 | -145 |
Financing Cash Flow | -8,558 | -7,745 | -3,433 | -5,125 | -6,469 | -8,877 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 62 | 92 | -40 | 57 | -63 | -35 |
Net Cash Flow | -298 | -2,428 | 3,906 | 673 | 74 | -659 |
Free Cash Flow | 9,639 | 9,456 | 10,305 | 7,421 | 8,344 | 10,805 |
Free Cash Flow Growth | 1.93% | -8.24% | 38.86% | -11.06% | -22.78% | 40.40% |
FCF Margin | 32.42% | 32.12% | 35.84% | 27.37% | 30.59% | 39.57% |
Free Cash Flow Per Share | 7.69 | 7.53 | 8.21 | 5.90 | 6.61 | 8.56 |
Levered Free Cash Flow | 3,266 | 5,338 | 3,199 | 5,043 | 3,110 | 3,122 |
Unlevered Free Cash Flow | 7,773 | 7,322 | 2,379 | 5,870 | 5,775 | 14,054 |